Table 2.

Proportion of patients with previous CVD risk assessment initiated on statins by QRISK2 category and time period

PeriodQRISK2 categoryPatients initiated on statin, n (%)Total patients in category, nGuideline-congruent initiations, n (%)
2012 to 2015≥20%6923 (35.0)19 781
10–19.9%5545 (13.8)40 272
0–9.9%2481 (2.7)91 735
Total14 949 (9.8)151 788N/A
Pre-guideline change (January 2012 to June 2014)≥20%3862 (36.7)10 531
10–19.9%2198 (12.8)17 117
0–9.9%1381 (3.6)38 258
Total7441 (11.3)65 9063862 (51.9)
Post-guideline change (July 2014 to December 2015)≥20%3061 (33.1)9250
10–19.9%3347 (14.4)23 155
0–9.9%1100 (2.1)53 477
Total7508 (8.7)85 8826408 (85.3)